GlassScriptPhysician profile
Jordan D Fein
NPI 1255316345
$87,303.88
in general payments reported to CMS, 2019-2025
19 companies · $28K in 2025
The $28K reported for 2025 was more than what 96% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,126 · 2020: $5,942 · 2021: $5,727 · 2022: $15K · 2023: $1,115 · 2024: $30K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50K · Travel and Lodging: $5,240 · Food and Beverage: $2,542 · Consulting Fee: $945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,135.00 |
| Travel and Lodging | $5,240.34 |
| Food and Beverage | $2,542.24 |
| Consulting Fee | $945.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $73,193.24 | 2019-2025 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $2,630.00 | 2021-2022 | |
| Vapotherm INC | $2,379.88 | 2019-2020 | |
| Pulmonx Corporation | $2,236.88 | 2020 | |
| Paratek Pharmaceuticals, INC. | $1,360.00 | 2021 | |
| Shire North American Group INC | $1,050.00 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $966.67 | 2020-2024 | |
| Zoll Medical Corporation | $753.34 | 2021-2023 | |
| Ethicon INC. | $727.54 | 2021 | |
| Smiths Medical Asd, INC. | $486.67 | 2020 | |
| Becton, Dickinson and Company | $393.33 | 2023 | |
| Dr.Reddy'S Laboratories,INC. | $355.00 | 2021 | |
| Erbe USA INC | $341.94 | 2025 | Cryo2 Vio3 |
| Melinta Therapeutics, LLC | $180.00 | 2022 | |
| Cipla USA INC. | $145.00 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $90.33 | 2023 | Acquire |
| Philips North America LLC | $14.06 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Fein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.